Demethylating drugs as novel analgesics for cancer pain. - Wikidata - awgldk - TriplyDB

Demethylating drugs as novel analgesics for cancer pain.

Demethylating drugs as novel analgesics for cancer pain.

http://www.wikidata.org/entity/Q34959705

about

Decitabine rescues cisplatin resistance in head and neck squamous cell carcinoma Neuron-restrictive silencer factor-mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain.DNA methylation at the mu-1 opioid receptor gene (OPRM1) promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion.DNA Methylation Modulates Nociceptive Sensitization after Incision.What pain tells us about cancer.The use of opioids for treatment of cancer pain.Drugging the pain epigenome.Ex vivo nonviral gene delivery of μ-opioid receptor to attenuate cancer-induced pain.Cutaneous pigmentation modulates skin sensitivity via tyrosinase-dependent dopaminergic signalling OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients.Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease

P2860

Q28544907-7DDB99CB-CFAA-4542-9809-FA398031C571 Q33595867-CC45DB27-26FC-4B98-A2EA-A4B9971E26B8 Q33688183-B94B8AFA-933D-4705-8EC3-1FA2620AC7CC Q35831786-7BFC5869-6215-46F9-B2B7-BE39B9096EF2 Q37561858-D7BE9EF4-D24E-4780-8F9A-E9888F4BDEB7 Q38281620-DF5CF6A4-5706-4F2A-A321-55659BB08376 Q38761806-6B9FC9DA-A6E7-4A2E-9B61-E337B4242E8B Q40378943-6E8DC22D-F879-44C6-BE3C-15EFD1A66245 Q41503978-B9EA5278-B733-4FB9-BB45-50951453934A Q44345268-BADF0104-E1C9-4DDB-877E-1E7E10FCEF8C Q58703542-2721B9FA-90DC-4BA2-8343-C03DCB8C2110

P2860

Demethylating drugs as novel analgesics for cancer pain.

http://www.wikidata.org/entity/Q34959705

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Demethylating drugs as novel analgesics for cancer pain.

@ast

Demethylating drugs as novel analgesics for cancer pain.

@en

Demethylating drugs as novel analgesics for cancer pain.

@nl

type

label

Demethylating drugs as novel analgesics for cancer pain.

@ast

Demethylating drugs as novel analgesics for cancer pain.

@en

Demethylating drugs as novel analgesics for cancer pain.

@nl

prefLabel

Demethylating drugs as novel analgesics for cancer pain.

@ast

Demethylating drugs as novel analgesics for cancer pain.

@en

Demethylating drugs as novel analgesics for cancer pain.

@nl

P1433

Q34959705-BF9FC36A-67FC-4D37-B208-DF53763E11F0

P1476

Q34959705-057AB9B4-02CB-41CC-BDB4-7EE065CD471F

P2093

Q34959705-2B169239-F51F-4CC4-9D19-68FC3F804405

Q34959705-520ECE91-1840-49E2-9D8C-1C5ECEAF2F4D

Q34959705-7050BAE3-C4EC-455A-AD77-4F0EC43B0E4E

Q34959705-77B6BBF5-C512-4C63-9B4F-6AA419A293C2

Q34959705-CA9BABB4-36D2-4C98-84BF-BAAF7390D0EC

P2860

Q34959705-0FFACC8B-6B4B-492E-87DF-443E81004AA4

Q34959705-101645AA-6681-4889-88ED-7B372309C428

Q34959705-10EC0932-8C52-44F4-8C11-EE320297C197

Q34959705-118003CA-B57D-46B5-885A-FA78341375C8

Q34959705-12EC3697-D81A-4143-8F9D-01A5DBE40474

Q34959705-2386A970-D2B6-450B-9898-31F3D30DD998

Q34959705-268602C8-E74D-4EC7-994A-A917B81F6C50

Q34959705-26F490E7-947C-40A3-A4E0-130CDEBAC878

Q34959705-270A87F6-AF35-4C40-8702-1E768BE4E6C4

Q34959705-292DFB0E-1A27-4C2A-ACBA-ED24C411EC8D

P304

Q34959705-1C5F17D9-4756-48EA-AC61-1BF95DB751D9

P31

Q34959705-4BD4C6A9-2239-4EBF-89DA-6B96B60430AD

P356

Q34959705-E9EA1FD9-C03E-4EDC-AC01-4F8BFD094C1E

P407

Q34959705-37FCD4BF-121E-4E45-9ADD-34054723EAF6

P433

Q34959705-8E9C26F0-9D37-47F4-B618-8C354115ED7C

P478

Q34959705-BD6C1755-EA65-436E-84B0-21975CD4007D

P50

Q34959705-EA5B68F0-157F-46E6-A7F6-69DD511A11B8

P577

Q34959705-793E0726-D736-4349-82CA-A0B6CD3AF36A

P698

Q34959705-66297B73-19D2-4ACD-AD7C-AAAE1B8005FA

P932

Q34959705-64AFAE42-B5D9-4275-952F-8BD8F5F0A800

P356

1078-0432.CCR-14-0901

P1433

Clinical Cancer Research

P1476

Demethylating drugs as novel analgesics for cancer pain

@en

P2093

Chi T Viet

http://www.w3.org/2001/XMLSchema#string

Dongmin Dang

http://www.w3.org/2001/XMLSchema#string

Kentaro Ono

http://www.w3.org/2001/XMLSchema#string

Ronald R Campbell

http://www.w3.org/2001/XMLSchema#string

Yi Ye

http://www.w3.org/2001/XMLSchema#string

P2860

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain.

Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

Expression of mu-opiate receptor in human epidermis and keratinocytes.

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.

DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action.

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy

P304

4882-4893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-14-0901

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Brian L. Schmidt

P577

2014-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24963050

http://www.w3.org/2001/XMLSchema#string

P932

4294581

http://www.w3.org/2001/XMLSchema#string